{"Title": ["BUZZ-U.S. STOCKS ON THE MOVE-L Brands, Akorn, Aurora Cannabis", "BUZZ-U.S. STOCKS ON THE MOVE-Akorn, L Brands, Aurora Cannabis", "Health Care Sector Update for 05/21/2020: AKRX, MDT, IMV, XLV, IBB", "BUZZ-U.S. STOCKS ON THE MOVE-Akorn, scPharmaceuticals, Teekay Tankers", "Akorn Files For Bankruptcy", "Forescout sues Advent to complete $1.9 billion merger", "Payments processor WEX threatens to abandon $1.7 bln deal for eNett and Optal", "Health Care Sector Update for 04/01/2020: IFRX, CEMI, AKRX, JNJ, PFE, ABT, MRK, AMGN", "BUZZ-U.S. STOCKS ON THE MOVE-L Brands, Akorn, Aurora Cannabis", "Health Care Sector Update for 03/26/2020: FREQ,AKRX,BMY,XLRN,AMN", "Health Care Sector Update for 03/26/2020: AKRX, BMY, XLRN, AMN", "Health Care Sector Update for 02/13/2020: AKRX, KERN, AVRO, JNJ, PFE, ABT, MRK, AMGN", "Akorn Continues To Evaluate Strategic Alternatives - Quick Facts", "Akorn (AKRX) Q3 2019 Earnings Call Transcript", "Akorn Updates 2019 Net Loss Guidance - Quick Facts", "Health Care Sector Update for 08/26/2019: AKRX, RKDA, SLRX", "Akorn Sale Process Impacted By Market Uncertainties - Quick Facts", "Akorn Q1 Loss Widens; But Stock Surges", "Here's Why Akorn Stock Rose as Much as 14.4% Today", "Mid-Day Update: US Stocks Little Changed as Market Searches for Direction After Long Holiday Weekend", "Options Traders Expect Huge Moves in Akorn (AKRX) Stock", "Akorn (AKRX) Q4 2018 Earnings Conference Call Transcript", "FDA flags concerns at Akorn's Amityville plant, shares slip", "FDA flags concerns at Akorn's Amityville plant", "Akorn (AKRX) Q2 2019 Earnings Call Transcript", "U.S. STOCKS ON THE MOVE-Constellation Brands, Chesapeake, Akorn, Micron", "5 Top Losers In Healthcare Sector (RHE, MBOT, AKRX...)", "U.S. STOCKS ON THE MOVE-Constellation, Akorn, Chesapeake, Teekay, XpresSpa", "Akorn gets FDA warning letter for Illinois plant, shares drop", "Akorn gets FDA warning letter for Illinois plant", "Akorn Gets FDA Warning Letter On Decatur, Illinois Manufacturing Facility", "Akorn gets warning letter from the FDA", "Akorn (AKRX) Gets FDA Warning Letter for Illinois Facility", "Health Care Sector Update for 01/08/2019: ORGO,EXEL,AXSM,AKRX", "Health Care Sector Update for 01/08/2019: EXEL,AXSM,AKRX", "FDA Nod For GNMK, AKRX Gets New CEO, PTI Plunges After-hours", "Here's Why Akorn Pharmaceuticals Is Sinking Today", "Pre-Market Most Active for Nov 28, 2018 : AMD, BKD, QQQ, VST, SQQQ, AKRX, XRAY, ROKU, GNL, VGR, TIF, AROC", "Do Options Traders Know Something About Akorn (AKRX) Stock We Don't?", "Is Akorn (AKRX) Stock a Suitable Pick for Value Investors?", "Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN", "Health Care Sector Update for 01/08/2019: ORGO,EXEL,AXSM,AKRX", "Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN", "Pre-Market Most Active for Oct 10, 2018 : NIO, QQQ, MU, GE, EXTR, CIEN, AKRX, PBR, CAG, ACHC, LSCC, SNAP", "Health Care Sector Update for 10/10/2018: NVCN,MYGN,PFE,IGC,AKRX", "Health Care Sector Update for 10/10/2018: MYGN,PFE,IGC,RARX,AKRX", "Mid-Day Market Update: Crude Oil Up Over 1%; Akorn Shares Plunge", "Here's Why Akorn Inc. Collapsed Today", "Here's Why Akorn, Inc. Fell 48.6% in October", "Why Infinera, Akorn, and Cal-Maine Foods Slumped Today", "Mid-Afternoon Market Update: Crude Oil Rises 2.5%; iFresh Shares Spike Higher", "November 9th Options Now Available For Akorn", "Is Akorn (AKRX) a Suitable Stock for Value Investors Now?", "AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?", "Bausch (BHC) Looks Good: Stock Adds 13.9% in Session", "Noteworthy Monday Option Activity: AKRX, PENN, DOCU", "Mid-Morning Market Update: Markets Open Higher; Cal-Maine Misses Q1 Views", "AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?", "Here's Why Akorn, Inc. Fell as Much as 24.1% Today", "Oversold Conditions For Akorn (AKRX)", "Notable Tuesday Option Activity: CBS, AKRX, HUBS", "Akorn (AKRX) Looks Good: Stock Adds 7.8% in Session", "Notable Thursday Option Activity: AKRX, PANW, PYPL", "Analysts Forecast 12% Upside For The Holdings of IWS", "Akorn Enters Oversold Territory", "Here's Why Akorn Inc Fell as Much as 16.4% Today", "Notable Monday Option Activity: AKRX, VRNS, CAT", "Why Akorn, Inc.'s Stock Is Up Big Today", "Relative Strength Alert For Akorn", "Mid-Morning Market Update: Markets Mostly Flat; Hasbro Misses Q1 Expectations", "Pre-Market Most Active for Apr 23, 2018 : MDR, AKRX, ERIC, CBI, TVIX, QQQ, AAPL, LYG, TOT, TLT, GE, KMB", "Health Care Sector Update for 04/23/2018: AKRX, PFE, FMS, HUM, BHVN", "Implied IWF Analyst Target Price: $153", "Health Care Sector Update for 04/23/2018: HSIC,BHVN,AKRX,FMS", "After Hours Most Active for Apr 10, 2018 : CMCSA, KMI, IP, QQQ, CZR, HRB, PAA, YEXT, BX, INTC, EXEL, AKRX", "Analysts Expect IWB Will Reach $169", "Notable Thursday Option Activity: AKRX, ELF, DLR", "Commit To Purchase Akorn At $7.50, Earn 28.9% Annualized Using Options", "Mid-Day Market Update: U.S. Stocks Turn Lower; Dillard's Shares Gain On Earnings Beat", "Here's Why Akorn, Inc. Stock Is Getting Thrashed Today", "Why Chicago Bridge & Iron, Akorn, and Flotek Industries Slumped Today", "Pre-Market Most Active for Feb 27, 2018 : AKRX, M, FIT, SBGL, TVIX, SAN, NOK, JCP, QCOM, QQQ, TLT, CMCSA", "Mid-Afternoon Market Update: Crude Oil Down 1.5%; Mallinckrodt Shares Climb After Strong Q4 Results", "Oversold Conditions For Akorn (AKRX)", "Akorn Reaches Analyst Target Price", "Commit To Purchase Akorn At $17.50, Earn 20.9% Annualized Using Options", "Notable Tuesday Option Activity: AKRX, ROK, CBRL", "Akorn Reaches Analyst Target Price", "Mid-Morning Market Update: Markets Open Higher; Macy's Profit Tops Estimates", "Akorn (AKRX) Shares Cross Below 200 DMA", "Perrigo Gets Technical Rating Upgrade", "Pre-Market Most Active for Oct 26, 2017 : NOK, MTU, TWTR, NMR, VIPS, RING, CELG, ABY, NVS, LSXMK, AKRX, QQQ", "Longfellow Investment Management Co Llc Buys Time Warner Inc, Atwood Oceanics Inc, Kite Pharma ...", "Pre-Market Most Active for Oct 18, 2017 : AUY, GFI, SFUN, EGO, RING, SBGL, IAG, ISBC, UPL, SSRM, PAAS, AKRX", "Perrigo Sees IBD RS Rating Improve To 73", "Akorn Enters Oversold Territory (AKRX)", "Noteworthy Wednesday Option Activity: AKRX, NXPI, WYNN", "Akorn (AKRX) Shares Cross Below 200 DMA", "Perrigo Gets Technical Rating Upgrade", "Akorn, Inc. (AKRX), Seaboard Corp (SEB) Lead 10 Notable Investor Filings", "Fresenius Buys Akorn -- What Now?", "Pre-Market Most Active for Apr 25, 2017 : APFH, AKRX, ESRX, ERIC, CATB, STM, KEP, BAC, SAN, CAT, XIV, NFLX", "4 Stocks with Strong Technical Momentum", "Magnetar Financial LLC Buys Reynolds American Inc, Level 3 Communications Inc, C.R. ...", "AKRX Crosses Above Average Analyst Target", "Pre-Market Most Active for Apr 10, 2017 : BBL, GERN, AKRX, NVO, BAC, MT, XIV, BHP, CHK, TSLA, QQQ, ASML", "Health Care Sector Update for 04/10/2017: AKRX,FMS,CYTX,OMED", "Akorn, Inc. (AKRX) Stock Soars on Possible Fresenius Deal", "Here's Why Akorn Inc. Rose as Much as 12.8% Today", "Close Update: Geopolitical Risks, Jobs Report Weigh on Stocks", "Why Diana Shipping, Akorn, and Granite Construction Jumped Today", "FPA Capital Buys 2 Beaten Down Stocks, Energy in Fourth Quarter", "AKRX Crosses Above Average Analyst Target", "Pre-Market Most Active for Apr 10, 2017 : BBL, GERN, AKRX, NVO, BAC, MT, XIV, BHP, CHK, TSLA, QQQ, ASML", "Mid-Day Market Update: Dow Falls 80 Points; Concert Pharma Shares Spike Higher", "New Strong Sell Stocks for March 6th", "Implied PPH Analyst Target Price: $63", "First Light Asset Management, LLC Buys Immunomedics, NeoGenomics, Shire PLC, Sells BioScrip, ...", "Commit To Buy Akorn At $17.50, Earn 12.6% Using Options", "Friday's ETF Movers: PJP, OIH", "These Indicators Show the Bull Market Has More Room to Run in \u2014\u2026\u20137", "Why Baytex Energy, Akorn, and Alamos Gold Jumped Today", "Why Akorn, Inc. Shares Are Surging 10%", "3 Reasons Akorn Inc. Could Fall", "Health Care Sector Update for 12/01/2016: AKRX,HTBX,ARDM", "Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?", "The Ridiculous Reason Akorn, Inc. Shares Dropped as Much as 17.4% Today", "Value Investing 2017: 3 Stocks to Put on Your Radar", "Commit To Buy Akorn At $20, Earn 10.2% Using Options", "Bullish Two Hundred Day Moving Average Cross - AKRX", "Peek Under The Hood: XPH Has 25% Upside", "Akorn Breaks Below 200-Day Moving Average - Notable for AKRX", "PPH's Holdings Imply 16% Gain Potential", "Noteworthy ETF Outflows: XPH, MNK, AKRX, HZNP", "Commit To Buy Akorn At $17.50, Earn 10.6% Using Options", "Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX", "Notable ETF Outflow Detected - XPH, RLYP, AKRX, JAZZ", "Akorn (AKRX) Shares Cross Below 200 DMA", "Akorn (AKRX) Shares March Higher, Can It Continue?", "Notable Tuesday Option Activity: MNST, IDCC, AKRX", "Teva's (TEVA) Stock Gains on Q1 Earnings & Revenue Beat", "Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Tops Q2 Estimates", "Friday's ETF Movers: GDXJ, IHE", "10 Biotech And Specialty Pharma Bargains - Do You Have The Guts To Speculate?", "Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge", "First Week of AKRX December 16th Options Trading", "Akorn (AKRX) Shares March Higher, Can It Continue?", "Relypsa Soars 67% in Thursday Trading on Buyout Rumors", "4 Top Ranked Healthcare Stocks that Surged Last Session", "First Week of AKRX May 20th Options Trading", "3 Value Stocks Near 52-Week Lows Worth Buying", "Oversold Conditions For Akorn (AKRX)", "Midday Update: Stocks Pare Initial Losses That Followed Belgium Terror Attacks, Nasdaq Composite Turns Positive in Afternoon Trade", "Mid-Day Market Update: Mattress Firm Drops Following Weak Results; NQ Mobile Shares Surge", "3 Beaten-Up Healthcare Stocks: Are They Bargains?", "Why Akorn, Inc. (AKRX), Lumber Liquidators Holdings Inc (LL) and Office Depot Inc (ODP) Are 3 of Today\u2019s Best Stocks", "Close Update: Wall Street Turns Negative as Terrorist Attack Lures Investors to Safe-Havens", "Health Care Sector Update for 03/22/2016: AKRX, CTRV", "Mid-Afternoon Market Update: US Stocks Gain; Sunedison Shares Tumble", "Health Care Sector Update for 03/22/2016: CLDN,AKRX,AAC", "Tuesday's ETF Movers: PJP, OIH", "Tuesday Sector Leaders: Drugs, Oil & Gas Refining & Marketing Stocks", "Thursday's ETF Movers: ILF, PJP", "How The Pieces Add Up: IWP Headed For $100", "John Paulson Increases Bet on Health Care for 7th Quarter", "Oversold Conditions For Akorn (AKRX)", "Commit To Buy Akorn At $17.50, Earn 10.9% Using Options", "Why Akorn, Inc. Is Soaring 39% Today", "Top-Notch Funds Buying Constellation, Northrop Grumman", "Wednesday's ETF Movers: PJP, GDXJ", "Noteworthy Monday Option Activity: ADXS, AKRX, CIEN", "Notable Thursday Option Activity: GOGO, OA, AKRX", "Akorn Becomes Oversold (AKRX)", "How We'll Clean Up Riding This Historic M&A Wave", "Akorn is Now Oversold (AKRX)", "Why Akorn, Inc. Stock Dropped 10% Today", "October 16th Options Now Available For Akorn (AKRX)", "Notable Two Hundred Day Moving Average Cross - AKRX", "A Pharma ETF Focused On Quality, Fast-Growing Stocks", "Commit To Buy Akorn At $40, Earn 15.6% Annualized Using Options", "Akorn (AKRX) Shares Cross Below 200 DMA", "Monday Sector Laggards: Biotechnology, Drugs", "3 Best Stocks for Investing in Generic Drugs", "Valeant's Glaucoma Drug Accepted for Review by the FDA", "October 16th Options Now Available For Akorn (AKRX)", "Actavis in Patent Infringement Lawsuit for Gilead's Letairis - Analyst Blog", "Teva, Xenon Start Phase II Postherpetic Neuralgia Study - Analyst Blog", "Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 5.5% - Tale of the Tape", "3 Reasons Why Akorn (AKRX) Is a Great Growth Stock - Tale of the Tape", "Mallinckrodt Reports Acthar Gel Data on Nephrotic Syndrome - Analyst Blog", "Health Care Sector Update for 03/20/2015: PRTO, AKRX, ICPT", "Can The Uptrend Continue for Akorn (AKRX)? - Tale of the Tape", "AstraZeneca Up on Positive Late-Stage Lung Disease Results - Analyst Blog", "Why Akorn (AKRX) Isn't Done Growing Earnings Yet - Tale of the Tape", "Teva Sells Four Oncology Development Assets to Ignyta - Analyst Blog", "AstraZeneca Presents Encouraging Heart Drug Brilinta Data - Analyst Blog", "Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog", "Pernix Therapeutics (PTX) in Focus: Stock Plunges 14.7% - Tale of the Tape", "Supernus Pharmaceuticals, Inc. (SUPN) Rises: Stock Up 10.8% - Tale of the Tape", "Strength Seen in Parnell (PARN): Stock Rises 9.1% - Tale of the Tape", "Wednesday 3/4 Insider Buying Report: AKRX, DPM", "Health Care Sector Update for 03/03/2015: AKRX,DRRX,MNKD", "Why Akorn Inc. Got Crushed Today", "Why Akorn, Inc. Sky-rocketed Higher Today", "First Week of AKRX April 17th Options Trading", "Lannett Joins Big-Game Hunt For Drugmaker Acquisitions", "After Hours Most Active for Jan 30, 2015 : PBR, AKRX, BAC, QCOM, PFE, GE, T, WFC, AAPL, MSFT, QQQ, CMCSA", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Financial Sector Update for 01/28/2015: UMBF,UIHC,EZPW", "First Week of AKRX September 18th Options Trading", "4 Screaming Growth Stocks to Buy", "Will Akorn (AKRX) Continue to Surge Higher? - Tale of the Tape", "Interesting AKRX Put And Call Options For February 2015", "Adamas Pharmaceuticals (ADMS) Jumps: Stock Gains 9.9% - Tale of the Tape", "Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog", "Financial Sector Update for 01/28/2015: UBNK,UIHC,EZPW", "Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog", "AxoGen, Inc. (AXGN) Jumps 5.45% on Insider Buying - Tale of the Tape", "Dr. Reddy's Laboratories (RDY) in Focus: Stock Falls 7.1% - Tale of the Tape", "3 Companies Growing Faster Than MannKind Corporation", "Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog", "Why Akorn (AKRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape", "Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog", "Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape", "Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog", "Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog", "Actavis Launches Generic of Shire's ADHD Drug Intuniv - Analyst Blog", "Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog", "First Week of January 2015 Options Trading For Akorn (AKRX)", "Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape", "Corium International (CORI) Jumps: Stock Moves 14.3% Higher - Tale of the Tape", "Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog", "Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Lannett Co. Gets Growth Rx In Generic Drugs Group", "Interesting AKRX Put And Call Options For June 2015", "5 Best Biotech Stocks to Buy Now", "First Week of AKRX November 22nd Options Trading", "Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape", "Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog", "Stocks with Upgraded Broker Ratings - Screen of the Week", "AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog", "Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog", "Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog", "Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog", "Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog", "Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog", "UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog", "Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog", "Should You Get Rid of Corium International (CORI) Now? - Tale of the Tape", "First Week of AKRX October 18th Options Trading", "Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog", "Supernus's SPN-810 Gets Fast Track Status for ADHD - Analyst Blog", "Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape", "Akorn (AKRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape", "Mallinckrodt Beats on Q3 Earnings and Revenues, Ups View - Analyst Blog", "Relypsa (RLYP) Worth Watching: Stock Gains 13.3% - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Why Akorn (AKRX) Might Be a Diamond in the Rough - Tale of the Tape", "Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape", "First Week of AKRX March 2015 Options Trading", "Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape", "Perrigo Beats on Q4 Earnings and Sales, Provides Guidance - Analyst Blog", "Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog", "Walgreens Sees Robust Growth in June Sales - Analyst Blog", "Edwards Lifesciences Monitor Gets FDA Nod - Analyst Blog", "Endo International to Expand Generics Business with DAVA Buy - Analyst Blog", "Akorn (AKRX) in Focus: Stock Moves 5.9% Higher - Tale of the Tape", "Aquinox Pharmaceuticals (AQXP) in Focus: Stock Plunges 15.1% - Tale of the Tape", "Teva's Nuvigil Patent Infringement Lawsuits Resolved - Analyst Blog", "Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape", "Acasti Pharma (ACST) Soars: Stock Adds 10.0% in Session - Tale of the Tape", "KaloBios (KBIO) Worth Watching: Stock Jumps 12.7% - Tale of the Tape", "Weakness Seen in Relypsa (RLYP): Stock Falls 7.4% - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Teva to Buy Labrys Biologics - Analyst Blog", "Milestone Payment for Supernus - Analyst Blog", "First Week of AKRX July 19th Options Trading", "Using the Short Ratio to Forecast Turning Points - Screen of the Week", "AdCare Health Systems (ADK) in Focus: Stock Moves 5.1% Higher - Tale of the Tape", "Merck Continues to Divest Ophthalmology Products - Analyst Blog", "Mallinckrodt Earnings Beat, Shares Dip on Low Revs - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "RadNet (RDNT) Surges: Stock Moves 21.8% Higher - Tale of the Tape", "Update on Actavis' Acquisitions - Analyst Blog", "Interesting AKRX Put And Call Options For May 17th", "Dr. Reddy's Misses Q4 Earnings Ests, Beats on Revs - Analyst Blog", "Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean Security Business For $1.93B", "Mid-Afternoon Market Update: Ukrainian Crisis Still Weighs on Select Equities as Plug Power Rallies on Cowen Note", "Pre-Market Earnings Report for March 3, 2014 : MGA, SSYS, ROC, NUS, PGH, AKRX, CLDX, RBA, EVEP, MGLN, SWC, SSW", "Akorn (AKRX) in Focus: Stock Moves 5.0% Higher - Tale of the Tape", "Concord Medical Services (CCM) in Focus: Stock Up 5.4% - Tale of the Tape", "India - An important Market for Mylan - Analyst Blog", "Akorn (AKRX) In Focus: Stock Jumps 8.1% - Tale of the Tape", "Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon Gains", "Microsemi Misses Q4 Earnings by a Penny - Analyst Blog", "Google's ???450m Data Center Expansion - Analyst Blog", "IRF Beats on Q1 Earnings - Analyst Blog", "Will Priceline.com (PCLN) Disappoint This Earnings? - Analyst Blog", "Will Tessera (TSRA) Disappoint This Earnings Season? - Analyst Blog", "Will Microsemi (MSCC) Miss Earnings Estimates? - Analyst Blog", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "OmniVision Unveils 13MP Sensor - Analyst Blog", "Microsemi Misses Q4 Earnings by a Penny - Analyst Blog", "Teva Slumps on CEO Departure - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Pernix Co-Promotes with Cumberland - Analyst Blog", "Actavis Q3 Earnings Grow, Guides Up - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Actavis Challenges Suboxone Film Patent - Analyst Blog", "Teva's Earnings Overshadowed by CEO Exit - Analyst Blog", "A Look at Actavis' Acquisitions - Analyst Blog", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Drugmaker Akorn Becoming Mighty Oak In Hi-Tech Merger", "Update on Alkermes' Portfolio - Analyst Blog", "Generic Launch at Mylan - Analyst Blog", "Actavis a Step Closer to WCRX - Analyst Blog", "Teva's Exclusive Launch of Generic Niacin - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "A Look at Actavis' Acquisitions - Analyst Blog", "Teva in Oncology Deals - Analyst Blog", "Good News for Mylan from India - Analyst Blog", "Teva's Nuvigil Fails in Bipolar I Study - Analyst Blog", "Teva-Rexahn Deal Terminated - Analyst Blog", "Stock Downgrades: Don't Buy Taser International, Bro!", "Akorn to Buy Hi-Tech Pharma - Analyst Blog", "Approval for Dr. Reddy's Generic Vidaza - Analyst Blog", "Sector Update: Healthcare Shares Lower; Hi-Tech Shares up 22% on Akorn's Acquisition Plans", "Sector Update: Healthcare", "After Hours Most Active for Aug 27, 2013 : JCP, QQQ, BAC, TIVO, AKRX, EBAY, INTC, MSFT, HPQ, XOM, PNM, AES", "Healthcare Stocks in Decline; Akorn, High-Tech Pharmacal Both Rise in Deal Seen Immediately Lifting EPS", "Sector Update: Healthcare", "Can the Recent Uptrend Continue for Akorn, Inc. (AKRX)? - Tale of the Tape", "Orphan Drug Status for Teva/Xenon Drug - Analyst Blog", "Setback for Acura Pharma - Analyst Blog", "Data on Teva's Milprosa - Analyst Blog", "Still Neutral on Mylan - Analyst Blog", "Teva's Quartette Approved in the US - Analyst Blog", "Dr. Reddy's Launches Generic Reclast - Analyst Blog", "Another Generic Launch at Mylan - Analyst Blog", "KaloBios Pharma Incurs Wider Loss - Analyst Blog", "Dr. Reddy's Launches Generic Accutane - Analyst Blog", "Favorable Court Ruling for Actavis - Analyst Blog", "Are These 4 Small Cap Growth Stocks Tomorrow's Industry Leaders?", "Are These 4 Small Cap Growth Stocks Tomorrow's Industry Leaders?", "Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL", "Hitting Your Next Home Run - Investment Ideas", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Akorn, Inc. Enters Oversold Territory - Tale of the Tape", "Akorn, Inc. - Momentum", "Data on Teva's Azilect - Analyst Blog", "Increasing Volume to Uncover Institutional Buying - Screen of the Week", "Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. - Press Releases", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Wall Street Experts: Deutsche Bank Loves These Stocks Boosted by Insider Buying", "Rallying Stocks: Will Small Investors Miss Out on the Rally, Again?", "Against the Herd: If Everyone Else is Selling Stocks, Should You?", "Investing 101: Rallying Stocks with Institutional and Insider Buying", "Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases", "Investing 101: Momentum Stocks with Insider Buying", "Investing 101: Rallying Healthcare Stocks Being Snapped By The Smart Money", "Investing 101: Finding Rallying Stocks Still Undervalued to Analyst Estimates", "Generics on the Rise: A Big Threat to Big Pharma?", "A Small Cap Company Worth Noting", "Inside the Numbers: 5 Stocks That Are Up in this Downturn", "Market Turmoil: What Should Investors Do Now?"], "Elapsed Time": ["MAY 21, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 20, 2020", "MAY 7, 2020", "APR 1, 2020", "MAY 21, 2020", "MAR 26, 2020", "MAR 26, 2020", "FEB 13, 2020", "FEB 10, 2020", "NOV 1, 2019", "OCT 31, 2019", "AUG 26, 2019", "APR 1, 2020", "MAY 7, 2019", "APR 22, 2019", "APR 22, 2019", "MAR 13, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "AUG 2, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 10, 2019", "JAN 8, 2019", "JAN 8, 2019", "DEC 20, 2018", "DEC 6, 2018", "NOV 28, 2018", "NOV 20, 2018", "NOV 19, 2018", "JAN 8, 2019", "JAN 8, 2019", "OCT 10, 2018", "OCT 10, 2018", "OCT 10, 2018", "OCT 10, 2018", "OCT 1, 2018", "OCT 1, 2018", "NOV 5, 2018", "OCT 1, 2018", "OCT 1, 2018", "SEP 28, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 10, 2018", "OCT 1, 2018", "AUG 27, 2018", "AUG 23, 2018", "AUG 23, 2018", "JUL 31, 2018", "JUL 13, 2018", "JUL 12, 2018", "JUN 4, 2018", "AUG 28, 2018", "MAY 2, 2018", "APR 30, 2018", "APR 27, 2018", "APR 23, 2018", "APR 23, 2018", "APR 23, 2018", "APR 23, 2018", "MAY 4, 2018", "APR 23, 2018", "APR 10, 2018", "APR 2, 2018", "MAR 29, 2018", "MAR 6, 2018", "FEB 27, 2018", "FEB 27, 2018", "APR 23, 2018", "FEB 27, 2018", "FEB 27, 2018", "FEB 23, 2018", "FEB 12, 2018", "FEB 6, 2018", "JAN 9, 2018", "JAN 1, 2018", "FEB 27, 2018", "DEC 21, 2017", "NOV 7, 2017", "OCT 26, 2017", "OCT 20, 2017", "OCT 18, 2017", "OCT 11, 2017", "AUG 17, 2017", "DEC 27, 2017", "DEC 21, 2017", "NOV 7, 2017", "MAY 5, 2017", "MAY 1, 2017", "APR 25, 2017", "APR 19, 2017", "AUG 14, 2017", "APR 10, 2017", "APR 10, 2017", "APR 10, 2017", "APR 10, 2017", "APR 10, 2017", "APR 7, 2017", "APR 7, 2017", "APR 11, 2017", "APR 10, 2017", "APR 10, 2017", "MAR 6, 2017", "MAR 6, 2017", "FEB 28, 2017", "FEB 16, 2017", "JAN 20, 2017", "APR 7, 2017", "JAN 2, 2017", "DEC 12, 2016", "DEC 12, 2016", "DEC 8, 2016", "DEC 1, 2016", "NOV 23, 2016", "NOV 3, 2016", "JAN 18, 2017", "OCT 20, 2016", "OCT 10, 2016", "SEP 23, 2016", "AUG 24, 2016", "AUG 22, 2016", "AUG 8, 2016", "JUL 22, 2016", "NOV 2, 2016", "JUN 14, 2016", "JUN 13, 2016", "MAY 19, 2016", "MAY 17, 2016", "MAY 10, 2016", "MAY 9, 2016", "MAY 6, 2016", "JUL 1, 2016", "MAY 6, 2016", "APR 21, 2016", "APR 14, 2016", "APR 8, 2016", "APR 7, 2016", "MAR 24, 2016", "MAR 24, 2016", "MAY 6, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 17, 2016", "MAR 7, 2016", "FEB 18, 2016", "FEB 5, 2016", "JAN 15, 2016", "MAR 22, 2016", "JAN 8, 2016", "NOV 18, 2015", "NOV 16, 2015", "NOV 5, 2015", "OCT 21, 2015", "OCT 12, 2015", "SEP 24, 2015", "JAN 15, 2016", "AUG 20, 2015", "AUG 6, 2015", "JUL 30, 2015", "JUN 26, 2015", "MAY 5, 2015", "APR 27, 2015", "APR 25, 2015", "SEP 23, 2015", "AUG 20, 2015", "APR 6, 2015", "APR 6, 2015", "APR 2, 2015", "MAR 31, 2015", "MAR 30, 2015", "MAR 20, 2015", "APR 13, 2015", "MAR 19, 2015", "MAR 18, 2015", "MAR 18, 2015", "MAR 18, 2015", "MAR 17, 2015", "MAR 13, 2015", "MAR 12, 2015", "MAR 19, 2015", "MAR 4, 2015", "MAR 3, 2015", "MAR 3, 2015", "FEB 26, 2015", "FEB 25, 2015", "FEB 24, 2015", "JAN 30, 2015", "MAR 5, 2015", "JAN 28, 2015", "JAN 23, 2015", "JAN 23, 2015", "JAN 19, 2015", "DEC 30, 2014", "DEC 26, 2014", "DEC 26, 2014", "JAN 28, 2015", "DEC 22, 2014", "DEC 19, 2014", "DEC 17, 2014", "DEC 17, 2014", "DEC 16, 2014", "DEC 15, 2014", "DEC 12, 2014", "DEC 24, 2014", "DEC 10, 2014", "DEC 8, 2014", "DEC 2, 2014", "DEC 2, 2014", "NOV 25, 2014", "NOV 19, 2014", "NOV 19, 2014", "DEC 11, 2014", "NOV 14, 2014", "NOV 13, 2014", "NOV 11, 2014", "OCT 27, 2014", "OCT 23, 2014", "OCT 21, 2014", "SEP 24, 2014", "NOV 14, 2014", "SEP 18, 2014", "SEP 16, 2014", "SEP 12, 2014", "SEP 10, 2014", "SEP 8, 2014", "SEP 5, 2014", "SEP 4, 2014", "SEP 23, 2014", "AUG 28, 2014", "AUG 21, 2014", "AUG 20, 2014", "AUG 19, 2014", "AUG 18, 2014", "AUG 18, 2014", "AUG 14, 2014", "SEP 3, 2014", "AUG 13, 2014", "AUG 11, 2014", "AUG 11, 2014", "AUG 11, 2014", "JUL 24, 2014", "JUL 22, 2014", "JUL 15, 2014", "AUG 14, 2014", "JUL 10, 2014", "JUL 8, 2014", "JUL 2, 2014", "JUN 25, 2014", "JUN 23, 2014", "JUN 23, 2014", "JUN 19, 2014", "JUL 10, 2014", "JUN 16, 2014", "JUN 11, 2014", "JUN 11, 2014", "JUN 9, 2014", "JUN 4, 2014", "MAY 22, 2014", "MAY 20, 2014", "JUN 17, 2014", "MAY 14, 2014", "MAY 14, 2014", "MAY 12, 2014", "MAY 12, 2014", "MAY 12, 2014", "APR 22, 2014", "MAR 26, 2014", "MAY 14, 2014", "MAR 3, 2014", "MAR 3, 2014", "FEB 28, 2014", "FEB 25, 2014", "JAN 9, 2014", "JAN 6, 2014", "NOV 18, 2013", "MAR 3, 2014", "NOV 8, 2013", "NOV 6, 2013", "NOV 5, 2013", "NOV 5, 2013", "NOV 5, 2013", "NOV 5, 2013", "NOV 4, 2013", "NOV 12, 2013", "OCT 31, 2013", "OCT 31, 2013", "OCT 29, 2013", "OCT 29, 2013", "OCT 29, 2013", "OCT 15, 2013", "OCT 9, 2013", "NOV 1, 2013", "OCT 8, 2013", "OCT 4, 2013", "OCT 4, 2013", "OCT 2, 2013", "OCT 1, 2013", "SEP 30, 2013", "SEP 23, 2013", "OCT 8, 2013", "OCT 8, 2013", "SEP 17, 2013", "SEP 4, 2013", "SEP 3, 2013", "AUG 30, 2013", "AUG 28, 2013", "AUG 28, 2013", "SEP 19, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 15, 2013", "APR 26, 2013", "AUG 27, 2013", "APR 18, 2013", "APR 15, 2013", "APR 4, 2013", "APR 4, 2013", "APR 4, 2013", "APR 3, 2013", "APR 1, 2013", "APR 19, 2013", "DEC 27, 2012", "DEC 27, 2012", "SEP 24, 2012", "JUL 18, 2012", "JUL 9, 2012", "APR 17, 2012", "FEB 8, 2012", "MAR 25, 2013", "JAN 24, 2012", "JAN 24, 2012", "JAN 20, 2012", "JAN 9, 2012", "NOV 3, 2011", "OCT 10, 2011", "SEP 27, 2011", "FEB 8, 2012", "SEP 20, 2011", "AUG 31, 2011", "AUG 17, 2011", "AUG 10, 2011", "AUG 1, 2011", "MAY 27, 2010", "SEP 26, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-l-brands-akorn-aurora-cannabis-2020-05-21", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-akorn-l-brands-aurora-cannabis-2020-05-21", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-21-2020%3A-akrx-mdt-imv-xlv-ibb-2020-05-21", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-akorn-scpharmaceuticals-teekay-tankers-2020-05-21", "https://www.nasdaq.com/articles/akorn-files-for-bankruptcy-2020-05-21", "https://www.nasdaq.com/articles/forescout-sues-advent-to-complete-%241.9-billion-merger-2020-05-20", "https://www.nasdaq.com/articles/payments-processor-wex-threatens-to-abandon-%241.7-bln-deal-for-enett-and-optal-2020-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-01-2020%3A-ifrx-cemi-akrx-jnj-pfe-abt-mrk-amgn-2020-04-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-l-brands-akorn-aurora-cannabis-2020-05-21", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-26-2020%3A-freqakrxbmyxlrnamn-2020-03-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-26-2020%3A-akrx-bmy-xlrn-amn-2020-03-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-13-2020%3A-akrx-kern-avro-jnj-pfe-abt-mrk-amgn-2020-02-13", "https://www.nasdaq.com/articles/akorn-continues-to-evaluate-strategic-alternatives-quick-facts-2020-02-10", "https://www.nasdaq.com/articles/akorn-akrx-q3-2019-earnings-call-transcript-2019-11-01", "https://www.nasdaq.com/articles/akorn-updates-2019-net-loss-guidance-quick-facts-2019-10-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-26-2019%3A-akrx-rkda-slrx-2019-08-26", "https://www.nasdaq.com/articles/akorn-sale-process-impacted-by-market-uncertainties-quick-facts-2020-04-01", "https://www.nasdaq.com/articles/akorn-q1-loss-widens-stock-surges-2019-05-07", "https://www.nasdaq.com/articles/heres-why-akorn-stock-rose-much-144-today-2019-04-22", "https://www.nasdaq.com/articles/mid-day-update-us-stocks-little-changed-market-searches-direction-after-long-holiday", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-akorn-akrx-stock-2019-03-13", "https://www.nasdaq.com/articles/akorn-akrx-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/fda-flags-concerns-akorns-amityville-plant-shares-slip-2019-02-28", "https://www.nasdaq.com/articles/fda-flags-concerns-akorns-amityville-plant-2019-02-28", "https://www.nasdaq.com/articles/akorn-akrx-q2-2019-earnings-call-transcript-2019-08-02", "https://www.nasdaq.com/articles/us-stocks-move-constellation-brands-chesapeake-akorn-micron-2019-01-09", "https://www.nasdaq.com/articles/5-top-losers-healthcare-sector-rhe-mbot-akrx-2019-01-09", "https://www.nasdaq.com/articles/us-stocks-move-constellation-akorn-chesapeake-teekay-xpresspa-2019-01-09", "https://www.nasdaq.com/articles/akorn-gets-fda-warning-letter-illinois-plant-shares-drop-2019-01-09", "https://www.nasdaq.com/articles/akorn-gets-fda-warning-letter-illinois-plant-2019-01-09", "https://www.nasdaq.com/articles/akorn-gets-fda-warning-letter-decatur-illinois-manufacturing-facility-2019-01-09", "https://www.nasdaq.com/articles/akorn-gets-warning-letter-fda-2019-01-09", "https://www.nasdaq.com/articles/akorn-akrx-gets-fda-warning-letter-for-illinois-facility-2019-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-01082019-orgoexelaxsmakrx-2019-01-08", "https://www.nasdaq.com/articles/health-care-sector-update-01082019-exelaxsmakrx-2019-01-08", "https://www.nasdaq.com/articles/fda-nod-gnmk-akrx-gets-new-ceo-pti-plunges-after-hours-2018-12-20", "https://www.nasdaq.com/articles/heres-why-akorn-pharmaceuticals-sinking-today-2018-12-06", "https://www.nasdaq.com/articles/pre-market-most-active-nov-28-2018-amd-bkd-qqq-vst-sqqq-akrx-xray-roku-gnl-vgr-tif-aroc", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-akorn-akrx-stock-we-dont-2018-11-20", "https://www.nasdaq.com/articles/is-akorn-akrx-stock-a-suitable-pick-for-value-investors-2018-11-19", "https://www.nasdaq.com/articles/health-care-sector-update-01082019-axsm-akrx-nvs-jnj-pfe-mrk-abt-amgn-2019-01-08", "https://www.nasdaq.com/articles/after-hours-most-active-oct-29-2018-akrx-znga-qqq-viav-xog-ebay-2018-10-29", "https://www.nasdaq.com/articles/health-care-sector-update-10102018-igc-akrx-jnj-pfe-abt-mrk-amgn-2018-10-10", "https://www.nasdaq.com/articles/pre-market-most-active-oct-10-2018-nio-qqq-mu-ge-extr-cien-akrx-pbr-cag-achc-lscc-snap", "https://www.nasdaq.com/articles/health-care-sector-update-10102018-nvcnmygnpfeigcakrx-2018-10-10", "https://www.nasdaq.com/articles/health-care-sector-update-10102018-mygnpfeigcrarxakrx-2018-10-10", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-1-akorn-shares-plunge-2018-10-01", "https://www.nasdaq.com/articles/heres-why-akorn-inc-collapsed-today-2018-10-01", "https://www.nasdaq.com/articles/heres-why-akorn-inc-fell-486-october-2018-11-05", "https://www.nasdaq.com/articles/why-infinera-akorn-and-cal-maine-foods-slumped-today-2018-10-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-rises-25-ifresh-shares-spike-higher-2018-10-01", "https://www.nasdaq.com/articles/november-9th-options-now-available-akorn-2018-09-28", "https://www.nasdaq.com/articles/is-akorn-akrx-a-suitable-stock-for-value-investors-now-2018-09-13", "https://www.nasdaq.com/articles/akrx-vs.-amph%3A-which-stock-should-value-investors-buy-now-2018-09-13", "https://www.nasdaq.com/articles/bausch-bhc-looks-good%3A-stock-adds-13.9-in-session-2018-09-13", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-akrx-penn-docu-2018-09-10", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-cal-maine-misses-q1-views-2018-10-01", "https://www.nasdaq.com/articles/akrx-vs.-amph%3A-which-stock-should-value-investors-buy-now-2018-08-27", "https://www.nasdaq.com/articles/heres-why-akorn-inc-fell-much-241-today-2018-08-23", "https://www.nasdaq.com/articles/oversold-conditions-akorn-akrx-2018-08-23", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-cbs-akrx-hubs-2018-07-31", "https://www.nasdaq.com/articles/akorn-akrx-looks-good%3A-stock-adds-7.8-in-session-2018-07-13", "https://www.nasdaq.com/articles/notable-thursday-option-activity-akrx-panw-pypl-2018-07-12", "https://www.nasdaq.com/articles/analysts-forecast-12-upside-holdings-iws-2018-06-04", "https://www.nasdaq.com/articles/akorn-enters-oversold-territory-2018-08-28", "https://www.nasdaq.com/articles/heres-why-akorn-inc-fell-much-164-today-2018-05-02", "https://www.nasdaq.com/articles/notable-monday-option-activity-akrx-vrns-cat-2018-04-30", "https://www.nasdaq.com/articles/why-akorn-incs-stock-big-today-2018-04-27", "https://www.nasdaq.com/articles/relative-strength-alert-akorn-2018-04-23", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-flat-hasbro-misses-q1-expectations-2018-04-23", "https://www.nasdaq.com/articles/pre-market-most-active-apr-23-2018-mdr-akrx-eric-cbi-tvix-qqq-aapl-lyg-tot-tlt-ge-kmb-2018", "https://www.nasdaq.com/articles/health-care-sector-update-04232018-akrx-pfe-fms-hum-bhvn-2018-04-23", "https://www.nasdaq.com/articles/implied-iwf-analyst-target-price-153-2018-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-04232018-hsicbhvnakrxfms-2018-04-23", "https://www.nasdaq.com/articles/after-hours-most-active-apr-10-2018-cmcsa-kmi-ip-qqq-czr-hrb-paa-yext-bx-intc-exel-akrx", "https://www.nasdaq.com/articles/analysts-expect-iwb-will-reach-169-2018-04-02", "https://www.nasdaq.com/articles/notable-thursday-option-activity-akrx-elf-dlr-2018-03-29", "https://www.nasdaq.com/articles/commit-purchase-akorn-750-earn-289-annualized-using-options-2018-03-06", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-lower-dillards-shares-gain-earnings-beat-2018-02-27", "https://www.nasdaq.com/articles/heres-why-akorn-inc-stock-getting-thrashed-today-2018-02-27", "https://www.nasdaq.com/articles/why-chicago-bridge-iron-akorn-and-flotek-industries-slumped-today-2018-04-23", "https://www.nasdaq.com/articles/pre-market-most-active-feb-27-2018-akrx-m-fit-sbgl-tvix-san-nok-jcp-qcom-qqq-tlt-cmcsa", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-15-mallinckrodt-shares-climb-after-strong-q4", "https://www.nasdaq.com/articles/oversold-conditions-akorn-akrx-2018-02-23", "https://www.nasdaq.com/articles/akorn-reaches-analyst-target-price-2018-02-12", "https://www.nasdaq.com/articles/commit-purchase-akorn-1750-earn-209-annualized-using-options-2018-02-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-akrx-rok-cbrl-2018-01-09", "https://www.nasdaq.com/articles/akorn-reaches-analyst-target-price-2018-01-01", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-macys-profit-tops-estimates-2018-02-27", "https://www.nasdaq.com/articles/akorn-akrx-shares-cross-below-200-dma-2017-12-21", "https://www.nasdaq.com/articles/perrigo-gets-technical-rating-upgrade-2017-11-07", "https://www.nasdaq.com/articles/pre-market-most-active-oct-26-2017-nok-mtu-twtr-nmr-vips-ring-celg-aby-nvs-lsxmk-akrx-qqq", "https://www.nasdaq.com/articles/longfellow-investment-management-co-llc-buys-time-warner-inc-atwood-oceanics-inc-kite", "https://www.nasdaq.com/articles/pre-market-most-active-oct-18-2017-auy-gfi-sfun-ego-ring-sbgl-iag-isbc-upl-ssrm-paas-akrx", "https://www.nasdaq.com/articles/perrigo-sees-ibd-rs-rating-improve-73-2017-10-11", "https://www.nasdaq.com/articles/akorn-enters-oversold-territory-akrx-2017-08-17", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-akrx-nxpi-wynn-2017-12-27", "https://www.nasdaq.com/articles/akorn-akrx-shares-cross-below-200-dma-2017-12-21", "https://www.nasdaq.com/articles/perrigo-gets-technical-rating-upgrade-2017-11-07", "https://www.nasdaq.com/articles/akorn-inc.-akrx-seaboard-corp-seb-lead-10-notable-investor-filings-2017-05-05", "https://www.nasdaq.com/articles/fresenius-buys-akorn-what-now-2017-05-01", "https://www.nasdaq.com/articles/pre-market-most-active-apr-25-2017-apfh-akrx-esrx-eric-catb-stm-kep-bac-san-cat-xiv-nflx", "https://www.nasdaq.com/articles/4-stocks-strong-technical-momentum-2017-04-19", "https://www.nasdaq.com/articles/magnetar-financial-llc-buys-reynolds-american-inc-level-3-communications-inc-cr-2017-08-14", "https://www.nasdaq.com/articles/akrx-crosses-above-average-analyst-target-2017-04-10", "https://www.nasdaq.com/articles/pre-market-most-active-apr-10-2017-bbl-gern-akrx-nvo-bac-mt-xiv-bhp-chk-tsla-qqq-asml-2017", "https://www.nasdaq.com/articles/health-care-sector-update-04102017-akrxfmscytxomed-2017-04-10", "https://www.nasdaq.com/articles/akorn-inc.-akrx-stock-soars-on-possible-fresenius-deal-2017-04-10", "https://www.nasdaq.com/articles/heres-why-akorn-inc-rose-much-128-today-2017-04-10", "https://www.nasdaq.com/articles/close-update-geopolitical-risks-jobs-report-weigh-stocks-2017-04-07", "https://www.nasdaq.com/articles/why-diana-shipping-akorn-and-granite-construction-jumped-today-2017-04-07", "https://www.nasdaq.com/articles/fpa-capital-buys-2-beaten-down-stocks-energy-fourth-quarter-2017-04-11", "https://www.nasdaq.com/articles/akrx-crosses-above-average-analyst-target-2017-04-10", "https://www.nasdaq.com/articles/pre-market-most-active-apr-10-2017-bbl-gern-akrx-nvo-bac-mt-xiv-bhp-chk-tsla-qqq-asml-2017", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-80-points-concert-pharma-shares-spike-higher-2017-03-06", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-6th-2017-03-06", "https://www.nasdaq.com/articles/implied-pph-analyst-target-price-63-2017-02-28", "https://www.nasdaq.com/articles/first-light-asset-management-llc-buys-immunomedics-neogenomics-shire-plc-sells-bioscrip", "https://www.nasdaq.com/articles/commit-buy-akorn-1750-earn-126-using-options-2017-01-20", "https://www.nasdaq.com/articles/fridays-etf-movers-pjp-oih-2017-04-07", "https://www.nasdaq.com/articles/these-indicators-show-bull-market-has-more-room-run-7-2017-01-02", "https://www.nasdaq.com/articles/why-baytex-energy-akorn-and-alamos-gold-jumped-today-2016-12-12", "https://www.nasdaq.com/articles/why-akorn-inc-shares-are-surging-10-2016-12-12", "https://www.nasdaq.com/articles/3-reasons-akorn-inc-could-fall-2016-12-08", "https://www.nasdaq.com/articles/health-care-sector-update-12012016-akrxhtbxardm-2016-12-01", "https://www.nasdaq.com/articles/is-mallinckrodt-mnk-poised-for-a-beat-in-q4-earnings-2016-11-23", "https://www.nasdaq.com/articles/ridiculous-reason-akorn-inc-shares-dropped-much-174-today-2016-11-03", "https://www.nasdaq.com/articles/value-investing-2017-3-stocks-put-your-radar-2017-01-18", "https://www.nasdaq.com/articles/commit-buy-akorn-20-earn-102-using-options-2016-10-20", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-akrx-2016-10-10", "https://www.nasdaq.com/articles/peek-under-hood-xph-has-25-upside-2016-09-23", "https://www.nasdaq.com/articles/akorn-breaks-below-200-day-moving-average-notable-akrx-2016-08-24", "https://www.nasdaq.com/articles/pphs-holdings-imply-16-gain-potential-2016-08-22", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xph-mnk-akrx-hznp-2016-08-08", "https://www.nasdaq.com/articles/commit-buy-akorn-1750-earn-106-using-options-2016-07-22", "https://www.nasdaq.com/articles/drug-stocks-q3-earnings-roster-for-nov-3-icpt-exel-akrx-2016-11-02", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xph-rlyp-akrx-jazz-2016-06-14", "https://www.nasdaq.com/articles/akorn-akrx-shares-cross-below-200-dma-2016-06-13", "https://www.nasdaq.com/articles/akorn-akrx-shares-march-higher-can-it-continue-2016-05-19", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-mnst-idcc-akrx-2016-05-17", "https://www.nasdaq.com/articles/tevas-teva-stock-gains-q1-earnings-revenue-beat-2016-05-10", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-tyson-foods-tops-q2-estimates-2016-05-09", "https://www.nasdaq.com/articles/fridays-etf-movers-gdxj-ihe-2016-05-06", "https://www.nasdaq.com/articles/10-biotech-and-specialty-pharma-bargains-do-you-have-guts-speculate-2016-07-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-us-stocks-turn-higher-endo-international-shares-plunge-2016-05", "https://www.nasdaq.com/articles/first-week-akrx-december-16th-options-trading-2016-04-21", "https://www.nasdaq.com/articles/akorn-akrx-shares-march-higher-can-it-continue-2016-04-14", "https://www.nasdaq.com/articles/relypsa-soars-67-thursday-trading-buyout-rumors-2016-04-08", "https://www.nasdaq.com/articles/4-top-ranked-healthcare-stocks-that-surged-last-session-2016-04-07", "https://www.nasdaq.com/articles/first-week-akrx-may-20th-options-trading-2016-03-24", "https://www.nasdaq.com/articles/3-value-stocks-near-52-week-lows-worth-buying-2016-03-24", "https://www.nasdaq.com/articles/oversold-conditions-akorn-akrx-2016-05-06", "https://www.nasdaq.com/articles/midday-update-stocks-pare-initial-losses-followed-belgium-terror-attacks-nasdaq-composite", "https://www.nasdaq.com/articles/mid-day-market-update-mattress-firm-drops-following-weak-results-nq-mobile-shares-surge", "https://www.nasdaq.com/articles/3-beaten-healthcare-stocks-are-they-bargains-2016-03-22", "https://www.nasdaq.com/articles/why-akorn-inc.-akrx-lumber-liquidators-holdings-inc-ll-and-office-depot-inc-odp-are-3-of", "https://www.nasdaq.com/articles/close-update-wall-street-turns-negative-terrorist-attack-lures-investors-safe-havens-2016", "https://www.nasdaq.com/articles/health-care-sector-update-03222016-akrx-ctrv-2016-03-22", "https://www.nasdaq.com/articles/mid-afternoon-market-update-us-stocks-gain-sunedison-shares-tumble-2016-03-22", "https://www.nasdaq.com/articles/health-care-sector-update-03222016-cldnakrxaac-2016-03-22", "https://www.nasdaq.com/articles/tuesdays-etf-movers-pjp-oih-2016-03-22", "https://www.nasdaq.com/articles/tuesday-sector-leaders-drugs-oil-gas-refining-marketing-stocks-2016-03-22", "https://www.nasdaq.com/articles/thursdays-etf-movers-ilf-pjp-2016-03-17", "https://www.nasdaq.com/articles/how-pieces-add-iwp-headed-100-2016-03-07", "https://www.nasdaq.com/articles/john-paulson-increases-bet-health-care-7th-quarter-2016-02-18", "https://www.nasdaq.com/articles/oversold-conditions-akorn-akrx-2016-02-05", "https://www.nasdaq.com/articles/commit-buy-akorn-1750-earn-109-using-options-2016-01-15", "https://www.nasdaq.com/articles/why-akorn-inc-soaring-39-today-2016-03-22", "https://www.nasdaq.com/articles/top-notch-funds-buying-constellation-northrop-grumman-2016-01-08", "https://www.nasdaq.com/articles/wednesdays-etf-movers-pjp-gdxj-2015-11-18", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-adxs-akrx-cien-2015-11-16", "https://www.nasdaq.com/articles/notable-thursday-option-activity-gogo-oa-akrx-2015-11-05", "https://www.nasdaq.com/articles/akorn-becomes-oversold-akrx-2015-10-21", "https://www.nasdaq.com/articles/how-well-clean-riding-historic-ma-wave-2015-10-12", "https://www.nasdaq.com/articles/akorn-now-oversold-akrx-2015-09-24", "https://www.nasdaq.com/articles/why-akorn-inc-stock-dropped-10-today-2016-01-15", "https://www.nasdaq.com/articles/october-16th-options-now-available-akorn-akrx-2015-08-20", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-akrx-2015-08-06", "https://www.nasdaq.com/articles/pharma-etf-focused-quality-fast-growing-stocks-2015-07-30", "https://www.nasdaq.com/articles/commit-buy-akorn-40-earn-156-annualized-using-options-2015-06-26", "https://www.nasdaq.com/articles/akorn-akrx-shares-cross-below-200-dma-2015-05-05", "https://www.nasdaq.com/articles/monday-sector-laggards-biotechnology-drugs-2015-04-27", "https://www.nasdaq.com/articles/3-best-stocks-investing-generic-drugs-2015-04-25", "https://www.nasdaq.com/articles/valeants-glaucoma-drug-accepted-for-review-by-the-fda-2015-09-23", "https://www.nasdaq.com/articles/actavis-and-rhythm-start-mid-stage-study-on-relamorelin-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/actavis-in-patent-infringement-lawsuit-for-gileads-letairis-analyst-blog-2015-04-06", "https://www.nasdaq.com/articles/teva-xenon-start-phase-ii-postherpetic-neuralgia-study-analyst-blog-2015-04-06", "https://www.nasdaq.com/articles/supernus-pharmaceuticals-supn-in-focus%3A-stock-up-5.5-tale-of-the-tape-2015-04-02", "https://www.nasdaq.com/articles/3-reasons-why-akorn-akrx-is-a-great-growth-stock-tale-of-the-tape-2015-03-31", "https://www.nasdaq.com/articles/mallinckrodt-reports-acthar-gel-data-on-nephrotic-syndrome-analyst-blog-2015-03-30", "https://www.nasdaq.com/articles/health-care-sector-update-03202015-prto-akrx-icpt-2015-03-20", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-akorn-akrx-tale-of-the-tape-2015-04-13", "https://www.nasdaq.com/articles/astrazeneca-up-on-positive-late-stage-lung-disease-results-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/why-akorn-akrx-isnt-done-growing-earnings-yet-tale-of-the-tape-2015-03-18", "https://www.nasdaq.com/articles/teva-sells-four-oncology-development-assets-to-ignyta-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/astrazeneca-presents-encouraging-heart-drug-brilinta-data-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/actavis-depression-drug-gains-fda-approval-for-new-dose-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/pernix-therapeutics-ptx-in-focus%3A-stock-plunges-14.7-tale-of-the-tape-2015-03-13", "https://www.nasdaq.com/articles/supernus-pharmaceuticals-inc.-supn-rises%3A-stock-up-10.8-tale-of-the-tape-2015-03-12", "https://www.nasdaq.com/articles/strength-seen-in-parnell-parn%3A-stock-rises-9.1-tale-of-the-tape-2015-03-19", "https://www.nasdaq.com/articles/wednesday-34-insider-buying-report-akrx-dpm-2015-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-03032015-akrxdrrxmnkd-2015-03-03", "https://www.nasdaq.com/articles/why-akorn-inc-got-crushed-today-2015-03-03", "https://www.nasdaq.com/articles/why-akorn-inc-sky-rocketed-higher-today-2015-02-26", "https://www.nasdaq.com/articles/first-week-akrx-april-17th-options-trading-2015-02-25", "https://www.nasdaq.com/articles/lannett-joins-big-game-hunt-drugmaker-acquisitions-2015-02-24", "https://www.nasdaq.com/articles/after-hours-most-active-jan-30-2015-pbr-akrx-bac-qcom-pfe-ge-t-wfc-aapl-msft-qqq-cmcsa", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2015-03-05", "https://www.nasdaq.com/articles/financial-sector-update-01282015-umbfuihcezpw-2015-01-28", "https://www.nasdaq.com/articles/first-week-akrx-september-18th-options-trading-2015-01-23", "https://www.nasdaq.com/articles/4-screaming-growth-stocks-buy-2015-01-23", "https://www.nasdaq.com/articles/will-akorn-akrx-continue-to-surge-higher-tale-of-the-tape-2015-01-19", "https://www.nasdaq.com/articles/interesting-akrx-put-and-call-options-february-2015-2014-12-30", "https://www.nasdaq.com/articles/adamas-pharmaceuticals-adms-jumps%3A-stock-gains-9.9-tale-of-the-tape-2014-12-26", "https://www.nasdaq.com/articles/actavis-alzheimers-drug-approved-bystolic-gets-crl-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/financial-sector-update-01282015-ubnkuihcezpw-2015-01-28", "https://www.nasdaq.com/articles/actavis-antibiotic-a-step-closer-to-eu-nod-chmp-positive-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/axogen-inc.-axgn-jumps-5.45-on-insider-buying-tale-of-the-tape-2014-12-19", "https://www.nasdaq.com/articles/dr.-reddys-laboratories-rdy-in-focus%3A-stock-falls-7.1-tale-of-the-tape-2014-12-17", "https://www.nasdaq.com/articles/3-companies-growing-faster-mannkind-corporation-2014-12-17", "https://www.nasdaq.com/articles/actavis-to-appeal-ruling-regarding-namenda-ir-sales-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/why-akorn-akrx-is-poised-to-beat-earnings-estimates-again-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/actavis-likely-to-continue-selling-namenda-ir-tablets-analyst-blog-2014-12-12", "https://www.nasdaq.com/articles/strength-seen-in-parnell-parn%3A-stock-moves-5.3-higher-tale-of-the-tape-2014-12-24", "https://www.nasdaq.com/articles/supernus-faces-new-patent-challenge-for-trokendi-xr-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/actavis-antibiotic-backed-for-fda-approval-response-in-q1-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/actavis-launches-generic-of-shires-adhd-drug-intuniv-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/teva-first-to-launch-a-generic-of-novartis-exforge-hct-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/first-week-january-2015-options-trading-akorn-akrx-2014-11-25", "https://www.nasdaq.com/articles/supernus-pharmaceuticals-supn-in-focus%3A-stock-up-9.8-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/corium-international-cori-jumps%3A-stock-moves-14.3-higher-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/supernus-faces-another-patent-challenge-for-oxtellar-xr-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/synageva-up-on-new-phase-iii-data-on-sebelipase-alfa-analyst-blog-2014-11-14", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-11-13", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/lannett-co-gets-growth-rx-generic-drugs-group-2014-10-27", "https://www.nasdaq.com/articles/interesting-akrx-put-and-call-options-june-2015-2014-10-23", "https://www.nasdaq.com/articles/5-best-biotech-stocks-buy-now-2014-10-21", "https://www.nasdaq.com/articles/first-week-akrx-november-22nd-options-trading-2014-09-24", "https://www.nasdaq.com/articles/akorn-akrx-worth-watching%3A-stock-adds-6.4-in-session-tale-of-the-tape-2014-11-14", "https://www.nasdaq.com/articles/impax-rytary-fda-action-date-extended-by-three-months-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/stocks-upgraded-broker-ratings-screen-week-2014-09-16", "https://www.nasdaq.com/articles/abbvies-humira-positive-in-phase-iii-skin-disease-study-analyst-blog-2014-09-12", "https://www.nasdaq.com/articles/actavis-bystolic-combination-gets-negative-fda-panel-vote-analyst-blog-2014-09-10", "https://www.nasdaq.com/articles/actavis-antibiotic-under-fda-review-response-in-1q15-analyst-blog-2014-09-08", "https://www.nasdaq.com/articles/mallinckrodts-pain-therapy-hits-phase-iii-primary-endpoint-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/actavis-gastrointestinal-drug-under-fda-priority-review-analyst-blog-2014-09-04", "https://www.nasdaq.com/articles/supernus-confirms-2014-outlook-epilepsy-products-in-focus-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/ucb-files-patent-infringement-lawsuit-vs.-actavis-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/actavis-up-on-positive-phase-iii-ceftazidime-avibactam-data-analyst-blog-2014-08-21", "https://www.nasdaq.com/articles/should-you-get-rid-corium-international-cori-now-tale-tape-2014-08-20", "https://www.nasdaq.com/articles/first-week-akrx-october-18th-options-trading-2014-08-19", "https://www.nasdaq.com/articles/mallinckrodt-acquires-questcor-to-join-sp-500-as-well-analyst-blog-2014-08-18", "https://www.nasdaq.com/articles/supernuss-spn-810-gets-fast-track-status-for-adhd-analyst-blog-2014-08-18", "https://www.nasdaq.com/articles/cerulean-pharma-ceru-worth-watching%3A-stock-soars-30.6-tale-of-the-tape-2014-08-14", "https://www.nasdaq.com/articles/akorn-akrx%3A-strong-industry-solid-earnings-estimate-revisions-tale-of-the-tape-2014-09-03", "https://www.nasdaq.com/articles/mallinckrodt-beats-on-q3-earnings-and-revenues-ups-view-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/relypsa-rlyp-worth-watching%3A-stock-gains-13.3-tale-of-the-tape-2014-08-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-08-11", "https://www.nasdaq.com/articles/why-akorn-akrx-might-be-a-diamond-in-the-rough-tale-of-the-tape-2014-08-11", "https://www.nasdaq.com/articles/acasti-pharma-acst-jumps%3A-stock-moves-7.3-higher-tale-of-the-tape-2014-07-24", "https://www.nasdaq.com/articles/first-week-akrx-march-2015-options-trading-2014-07-22", "https://www.nasdaq.com/articles/progenics-pharmaceuticals-inc.-pgnx-in-focus%3A-stock-rises-8.5-tale-of-the-tape-2014-07-15", "https://www.nasdaq.com/articles/perrigo-beats-on-q4-earnings-and-sales-provides-guidance-analyst-blog-2014-08-14", "https://www.nasdaq.com/articles/supernus-up-on-non-dilutive-royalty-deal-analyst-blog-2014-07-10", "https://www.nasdaq.com/articles/walgreens-sees-robust-growth-in-june-sales-analyst-blog-2014-07-08", "https://www.nasdaq.com/articles/edwards-lifesciences-monitor-gets-fda-nod-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/endo-international-to-expand-generics-business-with-dava-buy-analyst-blog-2014-06-25", "https://www.nasdaq.com/articles/akorn-akrx-in-focus%3A-stock-moves-5.9-higher-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/aquinox-pharmaceuticals-aqxp-in-focus%3A-stock-plunges-15.1-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/tevas-nuvigil-patent-infringement-lawsuits-resolved-analyst-blog-2014-06-19", "https://www.nasdaq.com/articles/acasti-pharma-inc.-acst-jumps%3A-stock-rises-7.6-tale-of-the-tape-2014-07-10", "https://www.nasdaq.com/articles/acasti-pharma-acst-soars%3A-stock-adds-10.0-in-session-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/kalobios-kbio-worth-watching%3A-stock-jumps-12.7-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/weakness-seen-in-relypsa-rlyp%3A-stock-falls-7.4-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-06-09", "https://www.nasdaq.com/articles/teva-to-buy-labrys-biologics-analyst-blog-2014-06-04", "https://www.nasdaq.com/articles/milestone-payment-for-supernus-analyst-blog-2014-05-22", "https://www.nasdaq.com/articles/first-week-akrx-july-19th-options-trading-2014-05-20", "https://www.nasdaq.com/articles/using-short-ratio-forecast-turning-points-screen-week-2014-06-17", "https://www.nasdaq.com/articles/adcare-health-systems-adk-in-focus%3A-stock-moves-5.1-higher-tale-of-the-tape-2014-05-14", "https://www.nasdaq.com/articles/merck-continues-to-divest-ophthalmology-products-analyst-blog-2014-05-14", "https://www.nasdaq.com/articles/mallinckrodt-earnings-beat-shares-dip-on-low-revs-analyst-blog-2014-05-12", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-05-12", "https://www.nasdaq.com/articles/radnet-rdnt-surges%3A-stock-moves-21.8-higher-tale-of-the-tape-2014-05-12", "https://www.nasdaq.com/articles/update-on-actavis-acquisitions-analyst-blog-2014-04-22", "https://www.nasdaq.com/articles/interesting-akrx-put-and-call-options-may-17th-2014-03-26", "https://www.nasdaq.com/articles/dr.-reddys-misses-q4-earnings-ests-beats-on-revs-analyst-blog-2014-05-14", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-tyco-sell-south-korean-security-business-193b", "https://www.nasdaq.com/articles/mid-afternoon-market-update-ukrainian-crisis-still-weighs-select-equities-plug-power", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-3-2014-mga-ssys-roc-nus-pgh-akrx-cldx-rba-evep-mgln-swc", "https://www.nasdaq.com/articles/akorn-akrx-in-focus%3A-stock-moves-5.0-higher-tale-of-the-tape-2014-02-25", "https://www.nasdaq.com/articles/concord-medical-services-ccm-in-focus%3A-stock-up-5.4-tale-of-the-tape-2014-01-09", "https://www.nasdaq.com/articles/india-an-important-market-for-mylan-analyst-blog-2014-01-06", "https://www.nasdaq.com/articles/akorn-akrx-in-focus%3A-stock-jumps-8.1-tale-of-the-tape-2013-11-18", "https://www.nasdaq.com/articles/mid-day-market-update-akorn-shares-slip-after-downbeat-outlook-dendreon-gains-2014-03-03", "https://www.nasdaq.com/articles/microsemi-misses-q4-earnings-by-a-penny-analyst-blog-2013-11-08", "https://www.nasdaq.com/articles/googles-450m-data-center-expansion-analyst-blog-2013-11-06", "https://www.nasdaq.com/articles/irf-beats-on-q1-earnings-analyst-blog-2013-11-05", "https://www.nasdaq.com/articles/will-priceline.com-pcln-disappoint-this-earnings-analyst-blog-2013-11-05", "https://www.nasdaq.com/articles/will-tessera-tsra-disappoint-this-earnings-season-analyst-blog-2013-11-05", "https://www.nasdaq.com/articles/will-microsemi-mscc-miss-earnings-estimates-analyst-blog-2013-11-05", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2013-11-04", "https://www.nasdaq.com/articles/omnivision-unveils-13mp-sensor-analyst-blog-2013-11-12", "https://www.nasdaq.com/articles/mylan-beats-on-earnings-revs-down-analyst-blog-2013-10-31", "https://www.nasdaq.com/articles/teva-slumps-on-ceo-departure-analyst-blog-2013-10-31", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2013-10-29", "https://www.nasdaq.com/articles/pernix-co-promotes-with-cumberland-analyst-blog-2013-10-29", "https://www.nasdaq.com/articles/actavis-q3-earnings-grow-guides-up-analyst-blog-2013-10-29", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2013-10-15", "https://www.nasdaq.com/articles/actavis-challenges-suboxone-film-patent-analyst-blog-2013-10-09", "https://www.nasdaq.com/articles/tevas-earnings-overshadowed-by-ceo-exit-analyst-blog-2013-11-01", "https://www.nasdaq.com/articles/a-look-at-actavis-acquisitions-analyst-blog-2013-10-08", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2013-10-04", "https://www.nasdaq.com/articles/drugmaker-akorn-becoming-mighty-oak-hi-tech-merger-2013-10-04", "https://www.nasdaq.com/articles/update-on-alkermes-portfolio-analyst-blog-2013-10-02", "https://www.nasdaq.com/articles/generic-launch-at-mylan-analyst-blog-2013-10-01", "https://www.nasdaq.com/articles/actavis-a-step-closer-to-wcrx-analyst-blog-2013-09-30", "https://www.nasdaq.com/articles/tevas-exclusive-launch-of-generic-niacin-analyst-blog-2013-09-23", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2013-10-08", "https://www.nasdaq.com/articles/fda-nod-for-new-formulation-of-tevas-treanda-analyst-blog-2013-09-18", "https://www.nasdaq.com/articles/teva-in-oncology-deals-analyst-blog-2013-09-17", "https://www.nasdaq.com/articles/good-news-for-mylan-from-india-analyst-blog-2013-09-04", "https://www.nasdaq.com/articles/tevas-nuvigil-fails-in-bipolar-i-study-analyst-blog-2013-09-03", "https://www.nasdaq.com/articles/teva-rexahn-deal-terminated-analyst-blog-2013-08-30", "https://www.nasdaq.com/articles/stock-downgrades-dont-buy-taser-international-bro-2013-08-28", "https://www.nasdaq.com/articles/akorn-to-buy-hi-tech-pharma-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/approval-for-dr.-reddys-generic-vidaza-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-hi-tech-shares-22-akorns-acquisition-plans-2013-08", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-27-1", "https://www.nasdaq.com/articles/after-hours-most-active-aug-27-2013-jcp-qqq-bac-tivo-akrx-ebay-intc-msft-hpq-xom-pnm-aes", "https://www.nasdaq.com/articles/healthcare-stocks-decline-akorn-high-tech-pharmacal-both-rise-deal-seen-immediately", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-27-0", "https://www.nasdaq.com/articles/can-the-recent-uptrend-continue-for-akorn-inc.-akrx-tale-of-the-tape-2013-08-15", "https://www.nasdaq.com/articles/orphan-drug-status-for-teva-xenon-drug-analyst-blog-2013-04-26", "https://www.nasdaq.com/articles/setback-for-acura-pharma-analyst-blog-2013-08-27", "https://www.nasdaq.com/articles/data-on-tevas-milprosa-analyst-blog-2013-04-18", "https://www.nasdaq.com/articles/still-neutral-on-mylan-analyst-blog-2013-04-15", "https://www.nasdaq.com/articles/tevas-quartette-approved-in-the-us-analyst-blog-2013-04-04", "https://www.nasdaq.com/articles/dr.-reddys-launches-generic-reclast-analyst-blog-2013-04-04", "https://www.nasdaq.com/articles/another-generic-launch-at-mylan-analyst-blog-2013-04-04", "https://www.nasdaq.com/articles/kalobios-pharma-incurs-wider-loss-analyst-blog-2013-04-03", "https://www.nasdaq.com/articles/dr.-reddys-launches-generic-accutane-analyst-blog-2013-04-01", "https://www.nasdaq.com/articles/favorable-court-ruling-for-actavis-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/are-these-4-small-cap-growth-stocks-tomorrows-industry-leaders-2012-12-27", "https://www.nasdaq.com/articles/are-these-4-small-cap-growth-stocks-tomorrows-industry-leaders-2012-12-27-0", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-asgn-cof-akrx-mcrs-gild-rop-pll-2012-09-24", "https://www.nasdaq.com/articles/hitting-your-next-home-run-investment-ideas-2012-07-18", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-07-09", "https://www.nasdaq.com/articles/akorn-inc.-enters-oversold-territory-tale-of-the-tape-2012-04-17", "https://www.nasdaq.com/articles/akorn-inc-momentum-2012-02-08", "https://www.nasdaq.com/articles/data-on-tevas-azilect-analyst-blog-2013-03-25", "https://www.nasdaq.com/articles/increasing-volume-uncover-institutional-buying-screen-week-2012-01-24", "https://www.nasdaq.com/articles/zackscom-featured-expert-kevin-matras-highlights-akorn-inc-diana-shipping-inc-endo", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-01-20", "https://www.nasdaq.com/articles/wall-street-experts-deutsche-bank-loves-these-stocks-boosted-insider-buying-2012-01-09", "https://www.nasdaq.com/articles/rallying-stocks-will-small-investors-miss-out-rally-again-2011-11-03", "https://www.nasdaq.com/articles/against-herd-if-everyone-else-selling-stocks-should-you-2011-10-10", "https://www.nasdaq.com/articles/investing-101-rallying-stocks-institutional-and-insider-buying-2011-09-27", "https://www.nasdaq.com/articles/zacks-releases-four-powerful-buy-stocks%3A-be-aerospace-yum-brands-akorn-and-h.b.-fuller", "https://www.nasdaq.com/articles/investing-101-momentum-stocks-insider-buying-2011-09-20", "https://www.nasdaq.com/articles/investing-101-rallying-healthcare-stocks-being-snapped-smart-money-2011-08-31", "https://www.nasdaq.com/articles/investing-101-finding-rallying-stocks-still-undervalued-analyst-estimates-2011-08-17", "https://www.nasdaq.com/articles/generics-rise-big-threat-big-pharma-2011-08-10", "https://www.nasdaq.com/articles/small-cap-company-worth-noting-2011-08-01", "https://www.nasdaq.com/articles/inside-numbers-5-stocks-are-downturn-2010-05-27", "https://www.nasdaq.com/articles/market-turmoil-what-should-investors-do-now-2011-09-26"], "Content": []}